Dementia prevention, intervention, and care: 2020 report of the Lancet Commission G Livingston, J Huntley, A Sommerlad, D Ames, C Ballard, S Banerjee, ... The lancet 396 (10248), 413-446, 2020 | 8925 | 2020 |
Dementia prevention, intervention, and care G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ... The lancet 390 (10113), 2673-2734, 2017 | 6682 | 2017 |
Assessment and management of behavioral and psychological symptoms of dementia HC Kales, LN Gitlin, CG Lyketsos Bmj 350, 2015 | 1369 | 2015 |
Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm DT Maust, HM Kim, LS Seyfried, C Chiang, J Kavanagh, LS Schneider, ... JAMA psychiatry 72 (5), 438-445, 2015 | 705 | 2015 |
Management of neuropsychiatric symptoms of dementia in clinical settings: recommendations from a multidisciplinary expert panel HC Kales, LN Gitlin, CG Lyketsos, ... Journal of the American Geriatrics Society 62 (4), 762-769, 2014 | 491 | 2014 |
Nonpharmacologic management of behavioral symptoms in dementia LN Gitlin, HC Kales, CG Lyketsos Jama 308 (19), 2020-2029, 2012 | 477 | 2012 |
Risk of mortality among individual antipsychotics in patients with dementia HC Kales, HM Kim, K Zivin, M Valenstein, LS Seyfried, C Chiang, ... American Journal of Psychiatry 169 (1), 71-79, 2012 | 424 | 2012 |
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission G Livingston, J Huntley, KY Liu, SG Costafreda, G Selbæk, S Alladi, ... The Lancet 404 (10452), 572-628, 2024 | 353 | 2024 |
Mortality risk in patients with dementia treated with antipsychotics versus other psychiatric medications HC Kales, M Valenstein, HM Kim, JF McCarthy, D Ganoczy, ... American Journal of Psychiatry 164 (10), 1568-1576, 2007 | 340 | 2007 |
Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus HC Kales, CG Lyketsos, EM Miller, C Ballard International psychogeriatrics 31 (1), 83-90, 2019 | 240 | 2019 |
Cerebrovascular disease and late-life depression HC Kales, DF Maixner, AM Mellow The American Journal of Geriatric Psychiatry 13 (2), 88-98, 2005 | 211 | 2005 |
Benzodiazepine use among depressed patients treated in mental health settings M Valenstein, KK Taylor, K Austin, HC Kales, JF McCarthy, FC Blow American Journal of Psychiatry 161 (4), 654-661, 2004 | 208 | 2004 |
Trends in antipsychotic use in dementia 1999-2007 HC Kales, K Zivin, HM Kim, M Valenstein, C Chiang, RV Ignacio, ... Archives of general psychiatry 68 (2), 190-197, 2011 | 202 | 2011 |
Detroit Expert Panel on Assessment and Management of Neuropsychiatric Symptoms of Dementia. Management of neuropsychiatric symptoms of dementia in clinical settings … HC Kales, LN Gitlin, CG Lyketsos J Am Geriatr Soc 62 (4), 762-769, 2014 | 201 | 2014 |
Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence A Kolanowski, M Boltz, E Galik, LN Gitlin, HC Kales, B Resnick, ... Nursing outlook 65 (5), 515-529, 2017 | 182 | 2017 |
Association of antipsychotic use with mortality risk in patients with Parkinson disease D Weintraub, C Chiang, HM Kim, J Wilkinson, C Marras, B Stanislawski, ... JAMA neurology 73 (5), 535-541, 2016 | 181 | 2016 |
Predictors of suicide in patients with dementia LS Seyfried, HC Kales, RV Ignacio, Y Conwell, M Valenstein Alzheimer's & dementia 7 (6), 567-573, 2011 | 170 | 2011 |
Rapid conversion of an outpatient psychiatric clinic to a 100% virtual telepsychiatry clinic in response to COVID-19 P Yellowlees, K Nakagawa, M Pakyurek, A Hanson, J Elder, HC Kales Psychiatric Services 71 (7), 749-752, 2020 | 161 | 2020 |
Rates of clinical depression diagnosis, functional impairment, and nursing home placement in coexisting dementia and depression HC Kales, P Chen, FC Blow, DE Welsh, AM Mellow The American Journal of Geriatric Psychiatry 13 (6), 441-449, 2005 | 160 | 2005 |
Managing behavioral and psychological symptoms of dementia LB Gerlach, HC Kales Psychiatric Clinics 41 (1), 127-139, 2018 | 148 | 2018 |